Knowledge Hub

Cytomegalovirus (CMV) Infection are Expected to Increase at a CAGR of 0.047% in 2023

Press Release   •   Feb 23, 2017 05:02 EST

DelveInsights Cytomegalovirus (CMV) Infection- Epidemiology Insights-2023-Global Report provides an overview of the disease and the historical and forecasted epidemiological data for the Cytomegalovirus (CMV) Infection for Global, United States, EU5 (France, Germany, Italy, Spain and United Kingdom) and Japan for the time period 2013-2023.

The report considers the transplant patients, HIV patients and Infants under high risk for CMV infections and epidemiology forecast for these high risk categories have also been taken into consideration. Of The 7 Major Markets, U.S. has the highest number of CMV Prevalent cases and Spain has the least number of CMV Prevalent cases. According to DelveInsight, the Global Diagnosed cases for Cytomegalovirus (CMV) Infection are expected to increase at a CAGR of 0.047% to 172,864 cases in 2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Get Sample Copy Of This Report @

http://www.marketresearchreports.biz/sample/sample/938618

Scope

  • Report covers the disease overview including etiology, pathophysiology, symptoms, diagnosis and disease management.
  • Identifying patient populations in the global Cytomegalovirus (CMV) Infection market
  • The Report covers the detailed historical and forecasted epidemiological data covering global from 2013-2023

Table of Content :

Cytomegalovirus Infections

Disease Overview

Symptoms of cytomegalovirus (CMV) Infection

Etiology

Risk Factors

Pathogenesis of human cytomegalovirus

Pathophysiology of cytomegalovirus infection

Diagnosis

Epidemiology and Patient Population

GLOBAL

Global CMV Prevalent, Diagnosed and Treatable Cases: Historical Data (2013-2015)

Global CMV Prevalent, Diagnosed and Treatable Cases: Forecasted Data (2016-2023)

United States

Total CMV Prevalent, Diagnosed and Treatable Cases: Historical Data (2013-2015)

Total CMV Prevalent, Diagnosed and Treatable Cases: Forecasted Data (2016-2023)

CMV Patients among Transplants: Historical Data (2013-2015)

CMV Patients among Transplants: Forecasted Data (2016-2023)

Infants Patients at High Risk of CMV: Historical Data (2013-2015)

Infants Patients at High Risk of CMV: Forecasted Data (2016-2023)

HIV Patients at High Risk of CMV: Historical Data (2013-2015)

HIV Patients at High Risk of CMV: Forecasted Data (2016-2023)

Europe

Italy

Total CMV Prevalent, Diagnosed and Treatable Cases: Historical Data (2013-2015)

Total CMV Prevalent, Diagnosed and Treatable Cases: Forecasted Data (2016-2023)

CMV Patients among Transplants: Historical Data (2013-2015)

CMV Patients among Transplants: Forecasted Data (2016-2023)

Infants Patients at High Risk of CMV: Historical Data (2013-2015)

Infants Patients at High Risk of CMV: Forecasted Data (2016-2023)

HIV Patients at High Risk of CMV: Historical Data (2013-2015)

HIV Patients at High Risk of CMV: Forecasted Data (2016-2023)

Spain

Total CMV Prevalent, Diagnosed and Treatable Cases: Historical Data (2013-2015)

Total CMV Prevalent, Diagnosed and Treatable Cases: Forecasted Data (2016-2023)

CMV Patients among Transplants: Historical Data (2013-2015)

CMV Patients among Transplants: Forecasted Data (2016-2023)

Infants Patients at High Risk of CMV: Historical Data (2013-2015)

Infants Patients at High Risk of CMV: Forecasted Data (2016-2023)

HIV Patients at High Risk of CMV: Historical Data (2013-2015)

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.